Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China
· Delayed Price · Currency is CNY 25.67
+0.29 (1.14%)
Mar 10, 2026, 10:45 AM CST
Wuhan Hvsen Biotechnology Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Market Capitalization | 5,116 | 1,660 | 2,364 | 3,356 | 4,735 | 4,413 | Upgrade
|
| Market Cap Growth | 164.09% | -29.79% | -29.56% | -29.11% | 7.30% | - | Upgrade
|
| Enterprise Value | 4,945 | 2,088 | 2,596 | 3,264 | 4,405 | 3,608 | Upgrade
|
| Last Close Price | 25.38 | 9.97 | 14.04 | 19.45 | 26.69 | 24.74 | Upgrade
|
| PE Ratio | 21.28 | - | 140.89 | 63.68 | 35.64 | 29.39 | Upgrade
|
| Forward PE | 28.52 | 20.96 | 30.44 | - | - | - | Upgrade
|
| PS Ratio | 3.07 | 1.38 | 2.32 | 3.28 | 4.75 | 5.68 | Upgrade
|
| PB Ratio | 2.42 | 1.13 | 1.57 | 2.18 | 2.93 | 3.20 | Upgrade
|
| P/TBV Ratio | 2.56 | 1.24 | 1.68 | 2.34 | 3.14 | 3.44 | Upgrade
|
| P/OCF Ratio | 23.48 | 38.13 | 25.44 | 34.72 | 30.41 | 91.26 | Upgrade
|
| EV/Sales Ratio | 2.97 | 1.74 | 2.55 | 3.19 | 4.42 | 4.64 | Upgrade
|
| EV/EBITDA Ratio | 14.53 | 15.88 | 20.45 | 26.41 | 26.89 | 19.88 | Upgrade
|
| EV/EBIT Ratio | 21.25 | 113.82 | 395.16 | 53.50 | 32.56 | 22.21 | Upgrade
|
| Debt / Equity Ratio | 0.15 | 0.61 | 0.56 | 0.51 | 0.42 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 0.92 | 6.76 | 6.63 | 6.40 | 4.16 | 0.44 | Upgrade
|
| Net Debt / Equity Ratio | -0.09 | 0.25 | 0.16 | 0.00 | -0.26 | -0.51 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.53 | 2.75 | 1.93 | 0.04 | -2.55 | -3.90 | Upgrade
|
| Net Debt / FCF Ratio | -1.49 | -2.39 | -2.67 | -0.01 | 0.94 | 3.88 | Upgrade
|
| Asset Turnover | 0.57 | 0.40 | 0.34 | 0.36 | 0.44 | 0.65 | Upgrade
|
| Inventory Turnover | 4.88 | 4.22 | 3.78 | 3.72 | 4.06 | 4.92 | Upgrade
|
| Quick Ratio | 1.32 | 1.08 | 1.25 | 1.42 | 2.70 | 3.03 | Upgrade
|
| Current Ratio | 1.71 | 1.42 | 1.62 | 1.68 | 3.18 | 3.48 | Upgrade
|
| Return on Equity (ROE) | 12.22% | -1.33% | 1.10% | 3.34% | 8.86% | 17.09% | Upgrade
|
| Return on Assets (ROA) | 4.95% | 0.38% | 0.14% | 1.33% | 3.76% | 8.45% | Upgrade
|
| Return on Invested Capital (ROIC) | 10.62% | 1.03% | 0.40% | 4.13% | 12.73% | 26.89% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.50% | 0.90% | 0.30% | 2.80% | 6.00% | 11.50% | Upgrade
|
| Earnings Yield | 4.21% | -1.21% | 0.71% | 1.57% | 2.81% | 3.40% | Upgrade
|
| FCF Yield | 2.37% | -9.09% | -3.87% | -9.90% | -9.39% | -4.14% | Upgrade
|
| Dividend Yield | 0.77% | 1.07% | 1.92% | 1.54% | 1.24% | 1.10% | Upgrade
|
| Payout Ratio | 26.33% | - | 349.40% | 118.55% | 36.08% | 3.99% | Upgrade
|
| Buyback Yield / Dilution | -8.54% | 0.06% | -0.33% | 0.19% | -12.59% | -18.45% | Upgrade
|
| Total Shareholder Return | -7.78% | 1.12% | 1.59% | 1.74% | -11.35% | -17.34% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.